Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include GlobeNewswire, Reuters, Endpoints News and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 141d ago.
Quick answers
Why is "Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (6)
- Ipsen to pay $1.75B for Kartos and its blood cancer asset FirstWord Pharma · 141d ago
- Ipsen to acquire Kartos Therapeutics, expanding hemato-oncology late-stage pipeline GlobeNewswire · 141d ago
- French biotech company Ipsen to buy Kartos Therapeutics for $450 million Reuters · 141d ago
- Ipsen to buy blood cancer company Kartos Therapeutics for $450M upfront Endpoints News · 141d ago
- Ipsen pens $1.7B deal to acquire Kartos for potential Jakafi add-on therapy for myelofibrosis Fierce Biotech · 141d ago
- Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion WSJ · 141d ago
Topics
Related trends
Best Buy's Black Friday Event Begins With Sitewide Savings on Apple, TVs, More
Best Buy launches its early Black Friday event with sitewide discounts on Apple products, Google devices, and TVs.
Best Buy's Early Black Friday Sale is Now Live, Including Deals on Gaming, Tech, and More
Best Buy launches its 2026 Black Friday sale early with deep discounts on Apple, Dyson, Bose and gaming gear across multiple product categories.
Google Plans to Spend $17 Billion on Wyoming Data Center
Google commits to spending $17 billion on artificial intelligence data center infrastructure in Wyoming.
Hackers Paid $15 to Drain $2.5 Billion From Binance in One Hit
A massive cryptocurrency heist involving Binance draws global attention as outlets report staggering financial losses and industry security concerns.
Exclusive | AstraZeneca Made $10 Billion Offer for Rhythm Pharmaceuticals
AstraZeneca reportedly made a $10 billion acquisition offer for obesity drugmaker Rhythm Pharmaceuticals.
‘GTA VI’ Hits Estimated $1.5 Billion In Sales—Before Launch, Report Says
1 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.